Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

The global diversity of fungi has been estimated between 2 to 11 million species, of which
only about 155 000 have been named. Most fungi are invisible to the unaided eye, but they …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

The epidemiology of invasive fungal infections is changing, with new populations at risk and
the emergence of resistance caused by the selective pressure from increased usage of …

Human fungal infections are a historically neglected area of disease research, yet they
cause more than 1.5 million deaths every year. Our understanding of the pathophysiology of …

Invasive fusariosis is a serious invasive fungal disease, affecting immunocompetent and,
more frequently, immunocompromised patients. Localized disease is the typical clinical form …

Access to the appropriate tools is crucial for early diagnosis and clinical management of
invasive fungal infections. This Review aims to describe the invasive fungal infection …

Paediatric patients with cancer and those undergoing allogeneic haematopoietic cell
transplantation have an increased susceptibility to invasive fungal diseases. In addition to …

Abstract Introduction: Invasive fungal infections (IFIs) in Asia/Pacific are a particular threat to
patients with malignancies, uncontrolled diabetes mellitus or undiagnosed/untreated human …